Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients

Jacques-Robert Christen (1) , Julien Bertolino (2) , Estelle Jean , Laurence Camoin (3, 4, 5) , Mikael Ebbo (6) , Jean-Robert Harlé (7) , Nicolas Schleinitz (8) , Gabrielle Sarlon (8) , Emmanuelle Bernit (9)

1 Hôpital d'Instruction des Armées Laveran
2 AMU MED - Aix-Marseille Université - Faculté de médecine
3 MEPHI - Microbes évolution phylogénie et infections
4 APHM - Assistance Publique - Hôpitaux de Marseille
5 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
6 Médecine Interne [Hôpital Saint-Joseph - Marseille]
7 Service de Chirurgie
8 TIMONE - Hôpital de la Timone [CHU - APHM]
9 DMI - MARSEILLE - Département de Médecine Interne

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Jacques-Robert Christen, Julien Bertolino, Estelle Jean, Laurence Camoin, Mikael Ebbo, et al.. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients. Hemoglobin, 2019, 43 (4-5), pp.296-299. ⟨10.1080/03630269.2019.1689997⟩. ⟨hal-02463172⟩